Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

497 > respiratory > Flashcards

respiratory Flashcards

1
Q

upper respiratory tract

A 
outside thorax 
Oronasopharynx
Pharynx
Larynx
Upper trachea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

lower respiratory tract

A 
within thorax
Lower trachea
Bronchi
Bronchioles
Alveolar duct
Alveoli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

conducting zone

A

nose to bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

respiratory zone

A

alveolar duct to alveoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

trachea

A

consists of 20 rings of cartilage, each backed with muscle and connective tissue, and lined with smooth tissue; lengthens and widens with each breath in and returning to normal with breath out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

epiglottis

A

prevents food from entering the tracheobronchial tree by closing over the glottis during swallowing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bronchi

A

airways of smooth muscle leading from trachea into lungs and branching into bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bronchioles

A

contain smooth muscle and no cartilage; and depend on the elastic recoil of the lung for patency. Each is capped with an alveolus cluster.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

alveoli

A

are the basic units of gas exchange; tiny, balloon-shaped air sacs in clusters at the end of the respiratory tree
Type I alveolar cells (pneumocytes) – responsible for the exchange of oxygen and carbon dioxide
Type II alveolar cells (pneumocytes) – are in the walls of the alveoli and secrete surfactant, a phospholipid protein that reduces the surface tension in the alveoli; without surfactant, the alveoli would collapse
Alveolar macrophages – phagocytize/eliminate foreign particles, dead cells, bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

accessory muscles of respiration

A

include Scalene, Pectoralis, Trapezius, Sternocleidomastoid, and Rectus abdominis muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

inhalation and expiration

A

Breathing in brings oxygen into lungs. The lungs remove the oxygen and pass it through to the bloodstream, where it is carried to the heart, and to tissues and organs.Breathing out removes the carbon dioxide in the lungs, from the blood from the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diaphragm is the main

A

respiratory muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

intercostal muscles expand and contract the thoracic space to

A

facilitate breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when you breathe in the diaphragm

A

pulls downward (contracts), creating a vacuum that causes a rush of air into your lungs; external intercostal muscles contract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when you breathe out the diaphragm

A

relaxes upward, pushing on your lungs, allowing them to deflate; internal intercostal contract and external intercostal muscles relax. Expiration occurs from passive, elastic recoil of lungs, rib cage and diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

forced/active inspiration

A

Sternocleidomastoid muscle elevates sternum
Scalene muscles elevate ribs
Pectoralis minor elevates ribs
Trapezius retract scapula to expand thoracic cavity
Diaphragm contracts more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

forced/active expiration

A

Rectus abdominis contract to push diaphragm up

Internal intercostals contract to compress lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ventilation perfusion mismatch

A

Decreased when there is decreased ventilation in lungs or increased perfusion (ie. More blood flow to lungs)
Increased when there is increased ventilation or decreased perfusion (ie. Less blood flow to lungs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

v/q ratio

A

The amount of air that reaches the alveoli divided by the amount of blood flow in the capillaries of the lungs
Normal V/Q ratio = 0.8
4 liters of oxygen pass through lungs each minute – ventilation
5 liters of blood pass through capillaries of lungs every minute – perfusion
ratio of amount of air reaching the alveoli per minute to the amount of blood reaching alveoli per minute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

v/q mismatch occurs when

A

ratio is higher or lower

- hypoxemia: below normal levels of oxygen in arterial blood and can lead to tissue hypoxia
- V/Q mismatch in ventilation and perfusion can arise due to either reduced ventilation of part of the 	lung or reduced perfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

reduced ventilation

A

Pneumonia – alveoli filled with exudate and unable to maintain ventilation
Asthma
COPD
V/Q ratio <1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

reduced perfusion of lungs

A

Pulmonary embolism – areas of pulmonary circulation obstructed, limiting blood flow to alveoli
Emphysema
V/Q ratio >1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

TLC

A

Total lung capacity – the volume in the lungs at maximal inflation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

FEV

A

Forced expiratory volume test – measures how much air a person can exhale in a forced breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

FVC

A

Forced vital capacity – total amount of air exhaled during the FEV test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

FRC

A

Functional Reserve Capacity – the volume of air in the lungs when the respiratory muscles are fully relaxed and no airflow is present; determined by the balance of the inward elastic recoil of the lungs and the outward elastic recoil of the chest wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

tidal volume

A

the normal volume of air displaced between normal inhalation and exhalation; 500ml per inspiration for young adult [7ml/kg of body mass]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

diffusing capacity

A

a measure of how well oxygen and carbon dioxide transfer/diffuse between the lungs and blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

adventitious breath sounds

A

crackles
wheezes
rhonchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

crackles

A

Air flowing by liquid
Fine are high-pitched crackling/Velcro
Coarse are low-pitched and gurgling
Sound drier higher in bronchial tree and wet lower in the bronchial tree

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

wheezes

A

Air flowing though constricted airways or an obstruction
High-pitched musical sound
Continuous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

rhonchi

A

Air flowing over thick secretions
Low-pitched sound
Continuous
Deep and low-pitched over the larger bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

alveolus

A

a sac that fills with air when we breathe in and allows air to pass across a membrane into a blood vessel (the alveolar capillary). Then, the sac contracts and deflates letting carbon dioxide out.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

airway

A

trachea, bronchi, bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

alveolar membranes

A

Allow oxygen to cross to the blood and carbon dioxide to cross out from the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

pulmonary blood vessels

A

bring blood to the lungs to pick up oxygen and release carbon dioxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

alveolar sac filled with something other than air

A

Pus as in pneumonia OR fluid with edema or blood

Prevents alveoli to hold normal oxygen and thus, decreases ability to adequately oxygenate blood in their capillaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

alveolar sac does not open adequately

A

Prevents adequate inspiration decreases amount of oxygen taken in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

alveolar sac unable to expire due to obstruction or decreased elastic recoil of sac

A

Prevent alveoli from fully deflating and can lead to retention of carbon dioxide; and blocking initiation of new breathing cycle

40
Q

destruction or thickening of membrane reduces

A

the diffusion of oxygen across it

Decreased surface area available for gas exchange

41
Q

loss of portions of membrane can occur with

A

emphysema

42
Q

thickening of membrane results from

A

fibrosis of the lungs
Connective tissue disease
Hypersensitivity
Exposure diseases—silicosis, asbestosis

43
Q

obstruction of blood vessels by pulmonary embolus prevents

A

transport of blood to the lungs for gas exchange

44
Q

pulmonary hypertension results from

A 
rise in blood pressure in the pulmonary arteries due to changes in the cells that line the vessels
Artery walls can become stiff and thick
Extra tissue may form
Vessels can become inflamed
Blood flow becomes restricted or blocked
45
Q

types of lung disease

A

-Obstructive: create difficulty for air to get out-Restrictive: cause difficulty for air to get in

46
Q

examples of obstructive lung disease

A

Mechanical obstruction of airway: foreign object, tumour, chronic mucus plug as in bronchitis
Increase resistance in the airways: airway thickening from inflammation in chronic bronchitis
Increased tendency for airway closure: asthma, emphysema

47
Q

examples of restrictive lung disease

A

Stiff lungs: interstitial lung disease

Stiff chest wall: kyphoscoliosis, obesity

Respiratory muscle weakness: neuromuscular disease

48
Q

obstructive lung disease

A

Lungs feel full
Wheezing
Mucus production
If airways obstructed, alveoli cannot contract well, making it hard to get the air out:
Total Lung Capacity and Residual Volume and Functional Residual Capacity increased

49
Q

restrictive lung disease

A

Feels hard to breathe enough air
Breathing difficulties may cause panic
If airways/chest restricted/limited, alveoli cannot expand well, making it hard to get air in:
Total Lung Capacity and Residual Volume and Functional Residual Capacity decreased

50
Q

disorders of the lower respiratory system

A 
bronchopulmonary dysplasia (BPD)
cystic fibrosis (CF)
51
Q

BPD occurs in

A

premature/low birth weight infants having persistent respiratory problems, requiring respiratory support
Underdevelopment of lungs in premature infant leading to need for oxygen and/or mechanical ventilation
Result of damage to lungs caused by mechanical ventilation and long-term oxygen use
Air pressure from ventilation damages fragile airways
Large amounts of oxygen damage the lining of the bronchi and alveoli
Infections
Chest wall or muscle weakness
Aspiration

52
Q

risk factors for BPD

A

Preterm delivery < 28 weeks
Birth weight < 1500 grams
Maternal womb infection (choriamnionitis)
Postnatal sepsis or pneumonia
Patent ductus arteriosus
Infants with small lungs (“Pulmonary hypoplasia”)
Male babies

53
Q

BPD leads to

A

the need for supplemental oxygen and mechanical ventilation

54
Q

BPD diagnosed when

A

When baby has trouble weaning from mechanical ventilation or requires extra oxygen at or after 36 weeks(gestational age)
Baby has cyanosis, cough, SOB
Changes on chest x-ray

55
Q

babies with BPD

A

Have fewer alveoli
Have larger alveoli with thicker walls
Cause the baby to have to work harder to breather and get enough oxygen

56
Q

clinical manifestations of BPD

A 
Hypoxemia 
Increased work of breathing
Hypercapnia
Bronchospasm with wheezing
Mucus plugging
Pulmonary hypertension
Tachypnea
Retractions
Nasal flaring
Right- sided heart failure
57
Q

living with BPD: chronic

A

Recurrent cough and wheezing are frequent
High susceptibility to repeated respiratory infections and their complications
Susceptible to viral infections and environmental exposures
Infants who survive are discharged home on home oxygen and some on ventilators
Good nutrition is required
Increased risk of asthma during childhood
Limitations on activity tolerance
Abnormal PFT’s indicate expiratory airflow obstruction and air trapping
Emotional impact of prolonged infant hospitalization for infant and parents
Compromised Pulmonary Function and defences
-can impact the circulatory system

58
Q

cystic fibrosis

A

Characterized by abnormal thick secretions that cause obstructive problems within the respiratory, digestive, and reproductive tracts
complex multisystem illness

59
Q

patho of CF

A

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
CFTR gene regulates the CFTR protein that functions as a channel across the membrane of cells that produce mucus, sweat, saliva, tears and digestive enzymes
CFTR protein regulates movement of chloride and sodium ions across epithelial cell membranes; maintains balance of salt and water
CFTR gene mutations generate CFTR protein dysfunctions – chloride becomes trapped in cells and no water hydration
Usually slippery, free-flowing mucus becomes thick and sticky
Respiratory tract and pancreas are predominantly affected.

60
Q

respiratory patho of CF

A

Bronchioles obstructed by thick mucus secretions
Impaired cilia functioning leading to decreased mucociliary clearance
Poor clearance of bacteria inhaled leading to predisposition for lung infections
Bacterial colonization with Pseudomonas aeruginosa and Staphylococcus aureus – common in CF
Pathogens cause inflammatory response
Chronic infection and ongoing inflammatory responses lead to destruction of the airway
Increased mechanical stress from increased obstruction of airway

61
Q

patho of pneumothorax with CF

A

Chronic infection and inflammation lead to dilation and damage to the bronchi
Airways become blocked and deformed
Cavitations or cysts, areas of brochiolar consolidation, fibrosis and air-trapping develop in the lung tissue
Air-trapping induces extra pressures in the alveolar tissue
Compromise respiratory adequacy
Blebs and bullae may develop in visceral pleura
From inflammation, irritation, and weakening of airway walls
Air leaks into pleural space exerting pressure on lung

62
Q

GI tract patho in CF

A

Thick secretions block ducts—pancreatic insufficiency, biliary obstruction, intestinal obstruction
Pancreatic duct becomes blocked with thick mucus
Digestive enzymes accumulate in pancreas – unable to travel to the small intestine
Impaired digestion and absorption of fat (steatorrhea) and protein (azotorrhea)
Malabsorption of fat-soluble vitamins A, D, E, K
Pancreas becomes inflamed
Damage to hormone cells – glucose intolerance
Insulin dependent diabetes
Meconium ileus (MI) in newborn – obstruction of the bowel by overly thick meconium
Distal intestinal obstruction syndrome (DIOS) – intestinal obstruction
Thick/congealed intestinal contents block lumen of small intestine
Rectal prolapse
Large, bulky stools, malnutrition, poor muscle tone, colon distension and increased intra-abdominal pressure due to coughing/distended bowel

63
Q

CF diagnostic evaluation

A

Canada-wide newborn screenings
Most cases identified through newborn screenings
Immunoreactive trypsinogen (IRT) protein levels checked
Genetic testing – mutations in CFTR
~ 10% not diagnosed until adolescence or early adulthood
Sweat chloride test – standard for confirming diagnosis
Infants >2 weeks of age [to obtain sufficient sweat]
For older children/adults [if not screened as infant]
Genetic or sweat testing with history of recurrent pancreatitis, chronic lung infections, bronchiectasis
Symptoms of chronic coughing, recurrent sinus infections, no weight gain, abnormal bowel movements, infertility
Family history – family member with CF or carrier

64
Q

pulmonary manifestations in CF

A

Initially
Recurrent wheezing, recurrent pneumonia
Chronic/recurrent dry nonproductive cough [early], developing purulent sputum later
Over time – ongoing obstruction and mucus accumulation
Bronchiectasis
Recurrent infections, dyspnea on exertion, paroxysmal cough, hemoptysis, chest pain, recurrent sinusitis and nasal polyps
Increased anteroposterior diameter of chest (barrel-shaped); cyanosis; clubbing of fingers and toes

65
Q

GI clinical manifestations in CF

A

Meconium ileus
Large, bulky, loose, frothy, foul-smelling stool (steatorrhea)
Rectal prolapse
Biliary cirrhosis with portal hypertension
Voracious appetite (early); loss of appetite (late)
FTT: Lack of weight gain, skeletal muscle wasting and weakness, failure to grow, distended abdomen
Thin extremities, vitamin deficiency, anemia

66
Q

genitourinary manifestations with CF

A

Male infertility
Congenital absence of vas deferens or blocked vas deferens
Female infertility
Highly viscous cervical secretions – impede sperm travel
Malnutrition can lead to anovulation and amenorrhea
Female incontinence
Frequent coughing weakens pelvic floor muscles

67
Q

using “CF PANCREAS” for presenting signs

A

Chronic cough and wheezing
Failure to thrive

Pancreatic insufficiency
Alkalosis and hypotonic dehydration
Neonatal intestinal obstruction (meconium ileus) Nasal polyps
Clubbing of fingers/chest radiograph with characteristics changes
Rectal prolapse
Electrolyte elevation in sweat, salty skin
Absence or congenital atresia of vas deferens
Sputum with Staph or Pseudomonas (mucoid)

68
Q

idiopathic pulmonary fibrosis (IPF)

A

Chronic, progressive, fibrosing disorder of the lower respiratory tract (limited to lungs).

69
Q

median survival for IPF

A

2-4 years after diagnosis

70
Q

usual onset for IPF

A

50-70 years of age

71
Q

common risk factors of IPF

A 
Cigarette smoking
Viral infection
Environmental pollutants
Chronic aspiration
GERD: acid reflux/heartburn
Genetic predisposition
More common in men than women
72
Q

patho of IPF

A

Exposure to an inciting agent (risk factors) in a susceptible host causes epithelial lung damage
Instead of initiation of normal wound healing to repair injured epithelium, abnormal activation leads to formation of fibroblastic/myofibroblastic centers – deposition and remodeling of matrix
Wound myofibroblasts which would normally apoptosize do not – leading to accumulation of myofibroblasts and excessive production of matrix proteins, fibrosis – leading to scarring and tissue stiffness/contraction
Fibrotic lung tissue reduces ability to expand leading to decreased lung compliance
Leads to increased WOB
Decreased tidal volume
Hypoventilation
Hypercapnia
Hypoxemia results from decreased diffusion of oxygen from alveoli to capillary

73
Q

clinical presentation of IPF

A

History:
Chronic exertional dyspnea
Chronic cough, non productive
Fatigue
Physical Examination:
Bilateral “Velcro-like” crackles [fine/dry crackles]
Clubbing
Acrocyanosis [extremities]
Physiological:
Resting hypoxemia
Low diffusion capacity of the lung (DLCO)
Normal or low forced vital capacity (FVC)
Chest X-Ray
Bilateral basal abnormalities, honeycombing/reticulation [net-like] - peripheral

74
Q

diagnosing IPF

A 
History
Physical examination: 
Dyspnea, cough, Velcro crackles
Pulmonary function testing 
High-resolution CT
Lung Biopsy [if necessary]
75
Q

presentation of patient with COPD

A 
Potential complications include:
Respiratory infections
Mental health
High blood pressure
Lung cancer
Heart
76
Q

emphysema

A

SOB = Shortness of breath
Alveoli are damaged
Over time, the inner walls of the air sacs weaken and rupture — creating larger air spaces instead of many small ones
Surface area of the lungs is reduced and the amount of oxygen that reaches the bloodstream is decreased

77
Q

presentation of patient with chronic bronchitis

A

Most common symptom: Persistent cough [present for most days in a month lasting for 3 months with at least 2 such episodes occurring for 2 years in a row] “smoker’s cough”
Coughing up mucus (expectoration)
Wheezing
Chest discomfort
Often have a cough and make mucus for many years before they have shortness of breath
History: Possible exposure to inhaled irritants/chemicals/smoking

78
Q

chronic bronchitis may lead to

A

Disability
Frequent and severe respiratory infections
Narrowing and plugging of
Trouble breathing

79
Q

other symptoms for chronic bronchitis may include

A 
Bluish fingernails, lips, and skin 
Wheezing and crackles
Swollen feet
Heart failure
The symptoms of chronic bronchitis may look like other lung conditions or health problems
80
Q

diagnostic tests for emphysema

A 
Chest x-ray
CT lung scan
Alpha-1 antitrypsin (AAT) test
Pulmonary function tests
Include spirometry
Arterial blood gas
81
Q

diagnostic tests for chronic bronchitis

A 
Chest x-ray
CT lung scan
Pulmonary function tests
Include spirometry
Arterial blood gas
82
Q

pulmonary hypertensioin

A

Mean elevated pulmonary artery pressures (PAP) > 25 mmHg at rest or > 30 mmHg with exercise
Pulmonary arterial hypertension (PAH) if PAP caused by abnormalities in pulmonary arterioles
Pulmonary venous hypertension (PVH) if PAP caused by abnormalities that increase left atrial pressure leading to back pressure in the pulmonary circulation

83
Q

pulmonary hypertension caused by

A

increased pulmonary vascular resistance or increased pulmonary venous pressure

84
Q

pulmonary hypertension leads to

A

right ventricular (RV) dilation and remodeling – then RV failure and death [when RV compensation cannot sustain normal cardiac function]

85
Q

patho of increased pulmonary vascular resistance

A

Endothelial and smooth muscle dysfunction leads to proliferation, hypertrophy and chronic inflammation AND Pathologic vasoconstriction occurs due to overproduction of vasoconstrictors and decreased production of vasodilators
Vasoconstriction leads to increase in pulmonary pressure and endothelium injuries [activating coagulation]
Lead to vascular wall remodeling resulting in fibrosis and thickening of vessel walls causing narrowing and further vasoconstriction

86
Q

patho of increased pulmonary venous pressure

A

Result of disorders that affect left side of heart and increase pressure in the left chambers
Leads to increased pressure in the pulmonary veins
This elevated pulmonary venous pressure causes damage to the alveolar-capillary wall and leads to edema
Constant high pressure lead to thickening in the walls of the alveolar-capillary membrane and decreases diffusion

87
Q

signs and symptoms of pulmonary hypertension

A 
Often not detected until severe
Early Symptoms may include:
Progressive exertional dyspnea
Fatigue
Chest discomfort
Tachypnea
Later Symptoms [signs of Right heart failure] may include:
Exertional presyncope
Peripheral edema
RV heave
S3
Jugular vein distention
Accentuation of the pulmonary component of the second heart sound
Tricuspid regurgitation murmur
88
Q

diagnosis of pulmonary hypertension

A

Exertional dyspnea
Initial confirmation:
Chest X-ray, spirometry, ECG to rule out other causes of dyspnea
Echocardiography (TTE) to assess RV function
CBC for erythrocytosis, anemia, thrombocytopenia
Additional tests:
V/Q, CT, pulmonary function tests
Serum autoantibody tests – to rule autoimmune
When confirmed pulmonary artery catherization to measure:
Right atrial pressure
Right ventricular pressure
Pulmonary artery pressure
Pulmonary artery occlusion pressure
Cardiac output
Left ventricular diastolic pressure

89
Q

cor pulmonale

A

Right ventricle enlargement (hypertrophy, dilation or both)
Secondary to a lung disorder that causes pulmonary artery hypertension increasing pressure on RV and leading to RV failure
Initially asymptomatic
Symptoms of dyspnea or exertional fatigue due to underlying lung disorder
Symptoms occur with exercise when cardiac output falls
As RV pressures increase may have [Right heart failure symptoms]:
Jugular vein distention
Peripheral edema
S3 and S4
Tricuspid regurgitation murmur
Chest pain
Chest X-Ray shows enlargement of RV and pulmonary artery
ECG may show RV hypertrophy

90
Q

common conditions and some general indications for lung transplants

A

Advanced chronic obstructive pulmonary disease [emphysema and chronic bronchitis]
Idiopathic pulmonary fibrosis
Cystic fibrosis
Idiopathic pulmonary arterial hypertension
Alpha 1-antitrypsin deficiency
Untreatable end-stage lung disease
Substantial limitation to daily activities – symptomatic with ADLs
Limited life expectancy: high risk of death to lung disease within 2 years
Ambulatory with rehabilitation potential
Acceptable nutritional status
Satisfactory psychosocial profile and emotional support system
Usually up to 65 years of age
High likelihood of surviving at least 90 days post transplant
High likelihood of 5-year post-transplant survival from general medical perspective

91
Q

types of lung transplants

A

Lobe – usually lower lobe removed and used to replace the recipient’s diseased lung; usually two lobes different donors
Single-Lung – one lung
Double-Lung – both lungs
Heart-Lung – both lungs and heart from a single donor
Living transplant – donor must be healthy and non-smoking and good match
Cadaveric transplant – most transplants from deceased organ donors

92
Q

donated lungs need to be

A

large enough to adequately oxygenate the recipient but small enough to fit with the chest cavity

93
Q

contraindications for lung transplants

A

Concurrent chronic illness such as congestive heart failure, kidney disease, liver disease
Other serious health conditions that will not improve following transplant
Current or recurrent infection that cannot be treated including HIV and hepatitis
Current or recent cancer
Health conditions that impair ability to tolerate surgery
Obesity – BMI > 35 kg/m2
Chest wall or spinal deformity that causes restriction
Current use of tobacco or illegal drugs
Alcohol dependency
Psychosocial problems/Psychiatric conditions
Noncompliance with medical instructions and therapies

94
Q

acute lung transplant rejection

A 
Flu-like symptoms
Fever
Fatigue
Dry Cough
Chest pain
Dyspnea on exertion
Decreased oxygen saturation (with exercise)
Decreased spirometry (> 10%)
Chest CT: Diffuse opacities
Crackles on physical examination
95
Q

chronic lung transplant rejection

A

Causes:
Bronchiolitis Obliterans Syndrome (BOS): inflammation and scarring/thickening of airways
Restrictive allograft syndrome (RAS) – lungs decrease in size
Symptoms:
Productive cough
Dyspnea at rest
Airway Obstruction
Infections: Pseudomonas aeruginosa; Aspergillus spp
Chest CT: bronchial wall thickening; opacities

96
Q

survival of lung transplant

A 
Median survival for single-lung transplants is 4.6 years; double-lung transplants I 6.6 years
Quality of life post transplant:
Most recipients are able to resume an unencumbered lifestyle
Over 9% report no activity limitations
Causes of death include:
Infection:  Aspergillus and cytomegalovirus 
Bronchiolitis obliterans
Graft failure
Diffuse alveolar damage caused by:
 Harvest injury
Acute antibody-mediated rejection
Severe acute rejection
Infection

497 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions